Reproducibility studies for experimental epitope detection in macrophages (EDIM)
Dennis Japink1, Marius Nap2, Meindert N Sosef3
1Department of General Surgery, Atrium Medical Center Parkstad, Henri Dunantstraat 5, 6419 PC Heerlen, The Netherlands; Department of General Surgery, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands; GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.
Journal of Immunological Methods
|April 2, 2014
Summary
Epitope detection in macrophages (EDIM) flow cytometry is a promising tool for cancer diagnosis. Validation confirms the EDIM assay is stable, reproducible, and transferable for clinical use.
Area of Science:
- Immunology
- Flow Cytometry
- Cancer Diagnostics
Background:
- Epitope detection in macrophages (EDIM) by flow cytometry has emerged as a promising technique.
- The method shows potential for diagnosing and monitoring malignancies.
- Further biological and technical validation is crucial for clinical application.
Purpose of the Study:
- To validate the technical and biological aspects of the EDIM assay.
- To assess pre-analytic and analytic phases for clinical readiness.
- To establish the reliability and transferability of the EDIM method.
Main Methods:
- Investigated pre-analytic and analytic phases of the EDIM assay.
- Assessed blood sample stability (24h post-venipuncture).
- Evaluated intra-individual variability, intra-assay and inter-assay variation, and assay transferability.
Main Results:
- EDIM assay samples are stable for 24 hours.
- Biological variation is comparable to serum tumor marker assays, with individual baseline values.
- Demonstrated good intra-assay reproducibility and inter-assay reproducibility similar to established tumor markers.
- Confirmed excellent transferability between analyzers.
Conclusions:
- The EDIM method is technically stable, reproducible, and transferable under optimal analytic conditions.
- Further research is needed to assess biological variation over time.
- The assay shows potential for reliable clinical use in malignancy diagnosis and follow-up.
